Type 1 diabetes results from autoimmune and/or inflammatry processes that selectively disrupt insulin-producing pancreatic β-cell, and is characterized by hyperglycemia due to reduced insulin secretion. This evidence concerns the gene INS and type 1 diabetes mellitus.